Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells (Q44205563)

30 November 2017

title

Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells (English)

1 reference

30 November 2017

1 reference

5

1 reference

30 November 2017

Shizhong Bu

1

1 reference

30 November 2017

Andree Blaukat

series ordinal

2

1 reference

30 November 2017

Xin Fu

series ordinal

3

1 reference

30 November 2017

Nils Erik Heldin

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

531

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

141-151

1 reference

Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

21 January 2018

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

The diagnosis of prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

The mammalian metabolite, 2-methoxyestradiol, affects P53 levels and apoptosis induction in transformed cells but not in normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

2-methoxyestradiol induces interferon gene expression and apoptosis in osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

MAPKs: new JNK expands the group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

The stress-activated protein kinase subfamily of c-Jun kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Signal transduction by the JNK group of MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Regulation of transcription by MAP kinase cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Prostaglandin F2alpha-induced Ca++ oscillations in human myometrial cells and the role of RU 486.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Three-dimensional mammary primary culture model systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

A Detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Heterotrimeric G proteins: organizers of transmembrane signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Structure-activity relationships for activation of adenylate cyclase by the diterpene forskolin and its derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Prognostic significance of apoptosis regulators in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Inactivation of Bcl-2 by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Microtubule-interfering Agents Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase through Both Ras and Apoptosis Signal-regulating Kinase Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

2-Methoxyestradiol-induced phosphorylation of Bcl-2: uncoupling from JNK/SAPK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Radiation-induced apoptosis in human myeloma cell line increases BCL-2/BAX dimer formation and does not result in BAX/BAX homodimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

2-Methoxyestradiol Arrests Cells in Mitosis without Depolymerizing Tubulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Superoxide dismutase as a target for the selective killing of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11 ; 14) chromosome translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Transplacental carcinogenesis by stilbestrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

SAPKs and transcription factors do the nucleocytoplasmic tango

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

c-Jun N-terminal kinase mediates apoptotic signaling induced by N-(4-hydroxyphenyl)retinamide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

17 beta-Estradiol potentiates kainate-induced currents via activation of the cAMP cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

Comparative properties of the catechol estrogens, I: methylation by catechol-O-methyltransferase and binding to cytosol estrogen receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903478-6

10.1016/S0014-5793(02)03478-6

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference